martes, 8 de diciembre de 2009

Prostate-specific antigen best practice statement: 2009 update.


GUIDELINE TITLE
Prostate-specific antigen best practice statement: 2009 update.

BIBLIOGRAPHIC SOURCE(S)
American Urological Association Education and Research, Inc. Prostate-specific antigen best practice statement: 2009 update. Linthicum (MD): American Urological Association Education and Research, Inc.; 2009. 82 p. [264 references]


GUIDELINE STATUS
This is the current release of the guideline.

This guideline updates a previous version: American Urological Association. Prostate-specific antigen (PSA) best practice policy. Oncology 2000 Feb;14(2):267-86. [130 references]

Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I. Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer. Urology 2001 Feb;57(2):217-24. [59 references]

Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I. Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up. Urology 2001 Feb;57(2):225-9. [38 references]


abrir aquí para acceder al documento NGC AHRQ completo:
Prostate-specific antigen best practice statement: 2009 update.

No hay comentarios:

Publicar un comentario